R & D projects (Q3312831)
Jump to navigation
Jump to search
Project Q3312831 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | R & D projects |
Project Q3312831 in Germany |
Statements
516,561.12 Euro
0 references
1,067,495.6 Euro
0 references
48.39 percent
0 references
17 March 2020
0 references
31 March 2022
0 references
HWI pharma services GmbH
0 references
49°13'20.17"N, 8°21'59.72"E
0 references
76761
0 references
Mit der innovativen Screening- und Technologie-Plattform lassen sich parenterale (sterile) Arzneimittel mit schwerlöslichen chemischen und biologischen Wirkstoffen mittels Nanotechnologie schneller, effizienter und kostengünstiger entwickeln und herstellen. (German)
0 references
With the innovative screening and technology platform, parenteral (sterile) medicines with insoluble chemical and biological agents can be developed and manufactured using nanotechnology faster, more efficiently and cost-effectively. (English)
25 October 2021
0 references
La plate-forme innovante de dépistage et de technologie permet de développer et de fabriquer des médicaments parentéral (stérilisés) à base d’ingrédients chimiques et biologiques insolubles à l’aide de nanotechnologies plus rapidement, plus efficacement et à moindre coût. (French)
6 December 2021
0 references
Met het innovatieve screening- en technologieplatform kunnen parenterale (steriele) geneesmiddelen met onoplosbare chemische en biologische agentia sneller, efficiënter en kosteneffectiever worden ontwikkeld en vervaardigd met behulp van nanotechnologie. (Dutch)
19 December 2021
0 references
Con l'innovativa piattaforma di screening e tecnologia, i medicinali parenterali (sterili) con agenti chimici e biologici insolubili possono essere sviluppati e fabbricati utilizzando nanotecnologie in modo più rapido, efficiente ed economico. (Italian)
18 January 2022
0 references
Germersheim
0 references
Identifiers
DE_TEMPORARY_15618
0 references